Explore Stanford technologies available for licensing:

Stanford scientists have discovered a new immunotherapeutic target for treating lung cancer and fibrotic lung disease.

Determining a patient's drug susceptibility is currently a lengthy process requiring hundred to millions of cells. Currently, these cells are labelled, frozen or otherwise manipulated in ways that prevent sequential testing against multiple drugs on the same few cells.

Stanford researchers in the Snyder lab have discovered and developed an innovative immunoglobulin modality for the treatment of insulin resistance and type 2 diabetes.

To date, there are no treatments to restore neurologic function for the 7 million US patients suffering from chronic ischemic stroke. NR1 therapy provides a novel treatment for this unmet need.

Stanford researchers have developed a novel catheter technology for sensing embolic delivery and reflux as a strategy to eliminate need for X-ray imaging during angiography.

Stanford researchers have developed a fabrication method for laser patterning stretchable electronics.

The Zhenan Bao Research Group at Stanford University developed and manufactured a photo-curable, directly patternable, stretchable, and highly conductive polymer that is ideal for bioelectronic applications, and stretchable electronic devices.

Scientists in the Zhenan Bao Research Group at Stanford developed a process for direct photo-patterning of electronic polymers that improves device density of elastic circuits over 100x.

The Zhenan Bao Research Group at Stanford University has designed an intrinsically stretchable polymeric matrix that allows seamless integration with physically crosslinked PEDOT:PSS, while stabilizing its high stretchability, and high conductivity after all necessary fabricat

The Problem: Chronic pain is best treated with a 'whole-person' approach that include behavioral/psychological approaches to pain self-management.

Chemical engineers at Stanford have developed miscible antifoams that are easy to incorporate and do not separate out from the target liquid during operation.

Researchers at Stanford University have identified a small molecule tryptase inhibitor for treatment of severe allergies. Mast cells are a part of the innate and adaptive immune response. Mast Cell activation results in release of granules containing tryptases.

Exhausted T cells are T cells that become dysfunctional after a period of time and play a role in reduced efficacy of T cell targeted immunotherapies.

Stanford researchers have developed a patented microscopy method which can provide chemical identification of molecular structures with radiation spectroscopy at nanometer or near-atomic scales, which is one of the most challenging problems in microscopy.

Stanford engineers have developed an optical modulator to enable low-cost and high spatial-resolution time-of-flight imaging and LiDAR with low-cost standard image sensors.